+
Site Tour
TENDYNE™
MITRAL VALVE
REPLACEMENT
TRANSCATHETER MITRAL VALVE
REPLACEMENT (TMVR)

 

Tendyne™ TMVR System is first-in-class technology designed to eliminate Mitral Regurgitation (MR),
offering selected patients with MR (≥ grade 3) a novel option for mitral valve replacement.

Features

DESIGNED FOR THE MITRAL ANATOMY TO ELIMINATE MR

TREAT MORE MR

IMPLANT WITH CONFIDENCE1

  • A wide array of sizes to provide appropriate fit for paravalvular sealing and LVOT area
  • AP dimension (mm): 26.4–41.3
  • Perimeter (mm): 96–143
  • Repositionable and retrievable intraoperatively, even after the valve is deployed
  • Robust pre-procedural planning support

Connext
Live

Bringing together the cardiovascular and stroke prevention community for live virtual events with the most respected KOLs. 

Find out more

 

TV

Transcatheter Mitral Valve implant

Transcatheter Mitral Valve implant : procedural and post-procedural echo guiding

Transcatheter Mitral Valve implant

Transcatheter Mitral Valve implant : patient selection and current evidence

Anatomical overview of the AV Valves

Anatomical overview of the AV Valves and structures

Screening Transmission | Mitral focus

Screening Transmission | Mitral focus

F. Maisano, M. Swaans, M. Adam. M. Weber

TriClip - AVVS 1 year 1 minute Tricuspid - Video

The most significant moments of the past year | Tricuspid focus

MitraClip - AVVS 1 year 1 minute Mitral - Video

The most significant moments of the past year | Mitral focus

AV Valves Summit 2024 | Closing of Day 2

AV  Valves Summit 2024 | Closing of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Trending Controversies | AV Valves

Trending Controversies | AV Valves

R. S. Von Bardeleben, M. Sitges, D. Tchetche, M. Swaans, M. Taramasso, C. Trani, K. Gatenby, M. Adamo, M. Barreiro, A. Linke, V. Ninios, J. Odenstedt, S. Berti, N. Ajmone Marsan

Case Parade | Mitral focus

Case Parade | Mitral focus

M. Sitges,  V. Ninios, J. Van der Heyden, K. Gatenby, D. Arzamendi, M. Shuvy, M. Adam

Review the Trends | Mitral focus

Review the Trends | Mitral focus

M. Metra, F. Maisano, N. Karam, R.S. Von Bardeleben, F. Bedogni, S. Samargandy

References

*The testimonial does not provide any indication, guide, warranty or guarantee as to the response patients may have to the treatment or effectiveness of the product or therapy in discussion. Opinions about the treatment discussed can and do vary and are specific to the individual’s experience and might not be representative of others.

**Tests performed by and data on file at Abbott.

  1. Tendyne™ IFU.
  2. Data on file at Abbott.
  3. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011.
    doi.org/10.1016/S0140-6736(06)69208-8.
  4. United States Census Bureau, 2010. Age and sex composition. Issued May 2011:1–16.
  5. Mirabel M, Lung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–1365.
    doi.org/10.1093/eurheartj/ehm001.
  6. Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report. J Am Coll Cardiol. 2017;70(19):2315–27.
    doi.org/10.1016/j.jacc.2017.09.015.
  7. Sorajja P, Moat N, Badhwar V, et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll Cardiol. 2019;73(11):1250–1260.
    doi.org/10.1016/j.jacc.2018.12.066.
  8. Gammie JS, Chikwe J, Badhwar V, et al. Isolated Mitral Valve Surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis.
    Ann Thorac Surg. 2018;106(3):716–27.
    doi.org/10.1016/j.athoracsur.2018.03.086.

© Abbott 2023. All rights reserved. 9-EH-5-14381-01 07-2023

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline